Molecular biology of hepatitis B virus infection

Virology

Volumn 479-480, Issue , 2015, Pages 672-686

  Seeger, Christoph ^a   Mason, William S ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Hepatitis b virus; Pathogenesis; Replication

Indexed keywords

MESSENGER RNA; VIRUS DNA; VIRUS RNA;

CHRONIC DISEASE; COMPLICATION; HEPATITIS B; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION; VIROLOGY; VIRUS REPLICATION;

CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER CIRRHOSIS; REVERSE TRANSCRIPTION; RNA, MESSENGER; RNA, VIRAL; VIRUS REPLICATION;

EID: 84939956694     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.02.031     Document Type: Review

References (223)

1. Afdhal N., Zeuzem S., Kwo P., Chojkier M., Gitlin N., Puoti M., Romero-Gomez M., Zarski J.P., Agarwal K., Buggisch P., Foster G.R., Brau N., Buti M., Jacobson I.M., Subramanian G.M., Ding X., Mo H., Yang J.C., Pang P.S., Symonds W.T., McHutchison J.G., Muir A.J., Mangia A., Marcellin P. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N. Engl. J. Med. 2014, 370:1889-1898.
2. Alter H.J., Holland P.V., Purcell R.H., Lander J.J., Feinstone S.M., Morrow A.G., Schmidt P.J. Posttransfusion hepatitis after exclusion of commercial and hepatitis-B antigen-positive donors. Ann. Int. Med. 1972, 77:691-699.
3. Bancroft W.H., Snitbhan R., Scott R.M., Tingpalapong M., Watson W.T., Tanticharoenyos P., Karwacki J.J., Srimarut S. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J. Infect. Dis. 1977, 135:79-85.
4. Barker L.F., Chisari F.V., McGrath P.P., Dalgard D.W., Kirschstein R.L., Almeida J.D., Edgington T.S., Sharp D.G., Peterson M.R. Transmission of type B viral hepatitis to chimpanzees. J. Infect. Dis. 1973, 127:648-652.
5. Bartenschlager R., Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 1992, 11:3413-3420.
6. Bayer M.E., Blumberg B.S., Werner B. Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature 1968, 218:1057-1059.
7. Beasley R.P., Lin C.C., Hwang L.Y., Chien C.S. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981, 2:1129-1133.
8. Becker S.A., Lee T.H., Butel J.S., Slagle B.L. Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol. 1998, 72:266-272.
9. Belloni L., Pollicino T., De Nicola F., Guerrieri F., Raffa G., Fanciulli M., Raimondo G., Levrero M. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc. Natl. Acad. Sci. USA 2009, 106:19975-19979.
10. Berquist K.R., Peterson J.M., Murphy B.L., Ebert J.W., Maynard J.E., Purcell R.H. Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus. J. Infect. Dis. 1973, 127:648-652.
11. Bertoletti A., Kennedy P.T. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell. Mol. Immunol. 2014, 10.1038/cmi.2014.79.
12. Bill C., Summers J. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc. Natl. Acad. Sci. USA 2004, 101:11135-11140.
13. Blanchet M., Sureau C. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J Virol 2007, 81:5841-5849.
14. Blumberg B.S. Australia antigen and the biology of hepatitis B. Science 1977, 197:17-25.
15. Blumberg B.S., Gerstley B.J.S., Hungerford D.A., London W.T., Sutnik A.I. A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis. Ann. Int. Med. 1967, 66:924-931.
16. Blumberg B.S., Larouze B., London W.T., Werner B., Hesser J.E., Millman I., Saimot G., Payet M. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am. J. Pathol. 1975, 81:669-682.
17. Bock C.T., Schwinn S., Locarnini S., Fyfe J., Manns M.P., Trautwein C., Zentgraf H. Structural organization of the hepatitis B virus minichromosome. J. Mol. Biol. 2001, 307:183-196.
18. Brunetto M.R., Rodriguez U.A., Bonino F. Hepatitis B virus mutants. Intervirology 1999, 42:69-80.
19. Bruni R., Conti I., Villano U., Giuseppetti R., Palmieri G., Rapicetta M. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks. Virology 2006, 345:258-269.
20. Bruni R., D'Ugo E., Giuseppetti R., Argentini C., Rapicetta M. Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma. Virology 1999, 257:483-490.
21. Bruss V. Hepatitis B virus morphogenesis. World J. Gastroenterol. 2007, 13:65-73.
22. Bruss V., Lu X., Thomssen R., Gerlich W.H. Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J. 1994, 13:2273-2279.
23. Buendia, M.A., Neuveut, C., 2015. Hepatocellular carcinoma. Cold Spring Harb. Perspect. Med. (in press). http://dx.doi.org/10.1101/CSHPERSPECT.a021444.
24. Burrell C.J., Gowans E.J., Jilbert A.R., Lake J.R., Marmion B.P. Hepatitis B virus DNA detection by in situ cytohybridization: implications for viral replication strategy and pathogenesis of chronic hepatitis. Hepatology 1982, 2:85S-91S.
25. Buynak E.B., Roehm R.R., Tytell A.A., Bertland A.U., Lampson G.P., Hilleman M.R. Vaccine against human hepatitis B. JAMA 1976, 235:2832-2834.
26. Chen C.J., Yang H.I. Natural history of chronic hepatitis B revealed. J. Gastroenterol. Hepatol. 2011, 26:628-638.
27. Chen M.T., Billaud J.N., Sallberg M., Guidotti L.G., Chisari F.V., Jones J., Hughes J., Milich D.R. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc. Natl. Acad. Sci. USA 2004, 101:14913-14918.
28. Chen S.M., Kung C.M., Yang W.J., Wang H.L. Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan. J. Clin. Virol. 2011, 52:11-16.
29. Chisari F.V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H.A., Sell S., Pinkert C.A., Brinster R.L., Palmiter R.D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989, 59:1145-1156.
30. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989, 244:359-362.
31. Choo Q.L., Weiner A.J., Overby L.R., Kuo G., Houghton M., Bradley D.W. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br. Med. Bull. 1990, 46:423-441.
32. Condreay L.D., Aldrich C.E., Coates L., Mason W.S., Wu T.T. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J. Virol. 1990, 64:3249-3258.
33. Cote P.J., Korba B.E., Steinberg H., Ramirez-Mejia C., Baldwin B., Hornbuckle W.E., Tennant B.C., Gerin J.L. Cyclosporin A modulates the course of woodchuck hepatitis virus infection and induces chronicity. J. Immunol. 1991, 146:3138-3144.
34. Crowther R.A., Kiselev N.A., Bottcher B., Berriman J.A., Borisova G.P., Ose V., Pumpens P. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 1994, 77:943-950.
35. Dandri M., Burda M.R., Will H., Petersen J. Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA. Hepatology 2000, 32:139-146.
36. Dane D.S., Cameron C.H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970, i:695-698.
37. Dejean A., Bougueleret L., Grzeschik K.H., Tiollais P. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 1986, 322:70-72.
38. Demers S.I., Russo P., Lettre F., Tanguay R.M. Frequent mutation reversion inversely correlates with clinical severity in a genetic liver disease, hereditary tyrosinemia. Hum. Pathol. 2003, 34:1313-1320.
39. Ding D., Lou X., Hua D., Yu W., Li L., Wang J., Gao F., Zhao N., Ren G., Lin B. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet. 2012, 8:e1003065.
40. Dupinay T., Gheit T., Roques P., Cova L., Chevallier-Queyron P., Tasahsu S.I., Le Grand R., Simon F., Cordier G., Wakrim L., Benjelloun S., Trepo C., Chemin I. Discovery of naturally occurring transmissible chronic hepatitis B virus infection among Macaca fascicularis from mauritius island. Hepatology 2013, 58:1610-1620.
41. Edmondson H.A., Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954, 7:462-503.
42. Engle R.E., Bukh J., Alter H.J., Emerson S.U., Trenbeath J.L., Nguyen H.T., Brockington A., Mitra T., Purcell R.H. Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors. Transfusion 2014, 54:2833-2841.
43. Evarts R.P., Nagy P., Marsden E., Thorgeirsson S.S. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987, 8:1737-1740.
44. Farber E., Sarma D.S. Hepatocarcinogenesis: a dynamic cellular perspective. Lab. Invest. 1987, 56:4-22.
45. Virus Taxonomy: Eighth Report of the International Committee of Taxonomy of Viruses: Hepadnaviridae 2005, 373-384. Elsevier Academic Press, San Diego, CA. C.M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, L.A. Ball (Eds.).
46. Feitelson M.A., Miller R.H. X gene-related sequences in the core gene of duck and heron hepatitis B viruses. Proc. Natl. Acad. Sci. USA 1988, 85:6162-6166.
47. Foster G.R., Ackrill A.M., Goldin R.D., Kerr I.M., Thomas H.C., Stark G.R. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc. Natl. Acad. Sci. USA 1991, 88:2888-2892.
48. Fourel G., Couturier J., Wei Y., Apiou F., Tiollais P., Buendia M.A. Evidence for long-range oncogene activation by hepadnavirus insertion. EMBO J. 1994, 13:2526-3254.
49. Fourel G., Trepo C., Bougueleret L., Henglein B., Ponzetto A., Tiollais P., Buendia M.A. Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature 1990, 347:294-298.
50. Fourel I., Saputelli J., Schaffer P., Mason W.S. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. J. Virol. 1994, 68:1059-1065.
51. Frelin L., Wahlstrom T., Tucker A.E., Jones J., Hughes J., Lee B.O., Billaud J.N., Peters C., Whitacre D., Peterson D., Milich D.R. A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection. J. Virol. 2009, 83:1379-1392.
52. Gerber M.A., Hadziyannis S., Vernace S., Vissoulis C. Incidence and nature of cytoplasmic hepatitis B antigen in hepatocytes. Lab. Invest. 1975, 32:251-256.
53. Gong S.S., Jensen A.D., Chang C.J., Rogler C.E. Double-stranded linear duck hepatitis B virus (DHBV) stably integrates at a higher frequency than wild-type DHBV in LMH chicken hepatoma cells. J. Virol. 1999, 73:1492-1502.
54. Gong S.S., Jensen A.D., Wang H., Rogler C.E. Duck hepatitis B virus integrations in LMH chicken hepatoma cells: identification and characterization of new episomally derived integrations. J. Virol. 1995, 69:8102-8108.
55. Govindarajan S., Conrad A., Lim B., Valinluck B., Kim A.M., Schmid P. Study of preneoplastic changes in liver cells by immunohistochemical and molecular hybridization techniques. Arch. Pathol. Lab. Med. 1990, 114:1042-1045.
56. Gowans E.J., Burrell C.J., Jilbert A.R., Marmion B.P. Detection of hepatitis B virus DNA sequences in infected hepatocytes by in situ cytohybridisation. J. Med. Virol. 1981, 8:67-78.
57. Gripon P., Cannie I., Urban S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 2005, 79:1613-1622.
58. Gripon P., Le Seyec J., Rumin S., Guguen-Guillouzo C. Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology 1995, 213:292-299.
59. Gripon P., Rumin S., Urban S., Le Seyec J., Glaise D., Cannie I., Guyomard C., Lucas J., Trepo C., Guguen-Guillouzo C. Infection of a human hepatoma cell line by hepatitis B virus. Proc. Natl. Acad. Sci. USA 2002, 99:15655-15860.
60. Grompe M. Liver stem cells, where art thou?. Cell Stem Cell 2014, 15:257-258.
61. Grompe M., Overturf K., Al-Dhalimy M., Finegold M. Therapeutic trials in the murine model of hereditary tyrosinemia type I: a progress report. J. Inherit. Metab. Dis. 1998, 21:518-531.
62. Guidotti L.G., Borrow P., Hobbs M.V., Matzke B., Gresser I., Oldstone M.B., Chisari F.V Viral cross talk: Intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc. Natl. Acad. Sci. USA 1996, 93:4589-4594.
63. Guidotti L.G., Chisari F.V. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 1996, 8:478-483.
64. Guo H., Mason W.S., Aldrich C.E., Saputelli J.R., Miller D.S., Jilbert A.R., Newbold J.E. Identification and classification of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. J. Virol. 2005, 79:2729-2742.
65. Guo J.T., Pryce M., Wang X., Barrasa M.I., Hu J., Seeger C. Conditional replication of duck hepatitis B virus in hepatoma cells. J. Virol. 2003, 77:1885-1893.
66. Guo J.T., Pugh J.C. Topology of the large envelope protein of duck hepatitis B virus suggests a mechanism for membrane translocation during particle morphogenesis. J. Virol. 1997, 71:1107-1114.
67. Guy C.S., Mulrooney-Cousins P.M., Churchill N.D., Michalak T.I. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 2008, 82:8579-8591.
68. Halpern M.S., Egan J., Mason W.S., England J.M. Viral antigen in endocrine cells of the pancreatic islets and adrenal cortex of Pekin ducks infected with duck hepatitis B virus. Virus Res. 1984, 1:213-223.
69. Halpern M.S., England J.M., Deery D.T., Petcu D.J., Mason W.S., Molnar K.K. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc. Natl. Acad. Sci. USA 1983, 80:4865-4869.
70. Higginson J., Grobbelaar B.G., Walker A.R.P. Hepatic fibrosis and cirrhosis in man in relation to malnutrition. Am. J. Pathol. 1957, 33:29-44.
71. Hirsch R.C., Loeb D.D., Pollack J.R., Ganem D. cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. J. Virol. 1991, 65:3309-3316.
72. Hoare M., Das T., Alexander G. Ageing, telomeres, senescence, and liver injury. J. Hepatol. 2010, 53:950-961.
73. Hoofnagle J.H. Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. J. Hepatol. 1990, 11:S100-S107.
74. Hoofnagle J.H. Reactivation of hepatitis B. Hepatology 2009, 49:S156-S165.
75. Hoofnagle J.H., Michalak T., Nowoslawski A., Gerety R.J., Barker L.F. Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. Gastroenterology 1978, 74:182-187.
76. Hosaka T., Suzuki F., Kumada H. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. Hepatology 2013, 58:98-107.
77. Hsia C.C., Evarts R.P., Nakatsukasa H., Marsden E.R., Thorgeirsson S.S. Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 1992, 16:1327-1333.
78. Hsu H.C., Wu T.T., Sheu J.C., Wu C.Y., Chiou T.J., Lee C.S., Chen D.S. Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma. Hepatology 1989, 9:747-750.
79. Hsu T., Moroy T., Etiemble J., Louise A., Trepo C., Tiollais P., Buendia M. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell 1988, 55:627-635.
80. Hu J., Seeger C. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 1996, 93:1060-1064.
81. Hu, J., Seeger, C., 2015. Hepadnavirus genome replication and persistance. Cold Spring Harb. Perspect. Med. (in press). http://dx.doi.org/10.1101/CSHPERSPECT.a021386.
82. Hu J., Toft D.O., Seeger C. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 1997, 16:59-68.
83. Huang J., Liang T. A novel hepatitis B virus (HBV) genetic element with rev response element-like properties that is essential for expression of HBV gene products. Mol. Cell. Biol. 1993, 13:7476-7486.
84. Huang Z.M., Yen T.S. Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J. Virol. 1994, 68:3193-3199.
85. Ishikawa T., Ganem D. The pre-S domain of the large viral envelope protein determines host range in avian hepatitis B viruses. Proc. Natl. Acad. Sci. USA 1995, 92:6259-6263.
86. Jiang S., Yang Z., Li W., Li X., Wang Y., Zhang J., Xu C., Chen P.J., Hou J., McCrae M.A., Chen X., Zhuang H., Lu F. Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis. PLoS One 2012, 7:e40363.
87. Jilbert A.R., Botten J.A., Miller D.S., Bertram E.M., Hall P.M., Kotlarski J., Burrell C.J. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection. Virology 1998, 244:273-282.
88. Jilbert A.R., Freiman J.S., Gowans E.J., Holmes M., Cossart Y.E., Burrell C.J. Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology 1987, 158:330-338.
89. Jilbert A.R., Wu T.T., England J.M., Hall P.M., Carp N.Z., O'Connell A.P., Mason W.S. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 1992, 66:1377-1388.
90. Kajino K., Jilbert A.R., Saputelli J., Aldrich C.E., Cullen J., Mason W.S. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J. Virol. 1994, 68:5792-5803.
91. Kaplan P.M., Greenman R.L., Gerin J.L., Purcell R.H., Robinson W.S. DNA polymerase associated with human hepatitis B antigen. J. Virol. 1973, 12:995-1005.
92. Kennedy S., Rettinger S., Flye M.W., Ponder K.P. Experiments in transgenic mice show that hepatocytes are the source for postnatal liver growth and do not stream. Hepatology 1995, 22:160-168.
93. Kian Chua P., Lin M.H., Shih C. Potent inhibition of human Hepatitis B virus replication by a host factor Vps4. Virology 2006, 354:1-6.
94. Koike K., Moriya K., Iino S., Yotsuyanagi H., Endo Y., Miyamura T., Kurokawa K. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994, 19:810-819.
95. Kordes C., Haussinger D. Hepatic stem cell niches. J. Clin. Invest. 2013, 123:1874-1880.
96. Kosovsky M.J., Qadry I., Siddiqui A. The regulation of hepatitis B virus gene expression: an overview of the cis- and trans-acting components. Hepatiits B Virus: Molecular Mechanism in Disease and Novel Strategies for Antiviral Therapy 1998, Imperial College Press, London. R. Koshy, W.H. Caselman (Eds.).
97. Kvittingen E.A., Rootwelt H., Berger R., Brantzaeg P. Self-induced progression of the genetic defect in tyrosinemia type I. J. Clin. Invest. 1994, 94:1657-1661.
98. Leupin O., Bontron S., Strubin M. Hepatitis B virus X protein and simian virus 5V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities. J. Virol. 2003, 77:6274-6283.
99. Li T., Robert E.I., van Breugel P.C., Strubin M., Zheng N. A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat. Struct. Mol. Biol. 2010, 17:105-111.
100. Lien J.M., Aldrich C.E., Mason W.S. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J. Virol. 1986, 57:229-236.
101. Lien J.M., Petcu D.J., Aldrich C.E., Mason W.S. Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J. Virol. 1987, 61:3832-3840.
102. Linnemann C.C., Kramer L.W., Askey P.A. Familial clustering of hepatitis B infections in gorillas. Am. J. Epidemiol. 1984, 119:424-430.
103. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
104. Lok A.S.F., McMahon B.J. Chronic hepatitis B: AAALD practice guidelines. Hepatology 2007, 45:507-539.
105. Lucifora J., Arzberger S., Durantel D., Belloni L., Strubin M., Levrero M., Zoulim F., Hantz O., Protzer U. Hepatitis B virus X protein is essential to initiate and maintain virus repliciation after infection. J. Hepatol. 2011, 55:996-1003.
106. Lucifora J., Xia Y., Reisinger F., Zhang K., Stadler D., Cheng X., Sprinzl M.F., Koppensteiner H., Makowska Z., Volz T., Remouchamps C., Chou W.M., Thasler W.E., Huser N., Durantel D., Liang T.J., Munk C., Heim M.H., Browning J.L., Dejardin E., Dandri M., Schindler M., Heikenwalder M., Protzer U. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 2014, 343:1221-1228.
107. Luckenbaugh L., Kitrinos K.M., Delaney W.E., Hu J. Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy. J. Viral Hepat. 2015, 10.1111/jvh.12361 (in press).
108. MacCallum F.O. Homologous serum hepatitis. Lancet 1947, 2:691-692.
109. Macrae D.R., Bruss V., Ganem D. Myristylation of a duck hepatitis B virus envelope protein is essential for infectivity but not for virus assembly. Virology 1991, 181:359-363.
110. Madden C.R., Finegold M.J., Slagle B.L. Hepatitis B virus×protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J. Virol. 2001, 75:3851-3858.
111. Mancini R., Marucci L., Benedetti A., Jezequel A.M., Orlandi F. Immunohistochemical analysis of S-phase cells in normal human and rat liver by PC10 monoclonal antibody. Liver 1994, 14:57-64.
112. Marcellin P., Gane E., Buti M., Afdhal N., Sievert W., Jacobson I.M., Washington M.K., Germanidis G., Flaherty J.F., Schall R.A., Bornstein J.D., Kitrinos K.M., Subramanian G.M., McHutchison J.G., Heathcote E.J. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 2013, 381:468-475.
113. Marion P.L., Oshiro L.S., Regnery D.C., Scullard G.H., Robinson W.S. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA 1980, 77:2941-2945.
114. Marion P.L., Van D.M., Knight S.S., Salazar F.H., Garcia G., Popper H., Robinson W.S. Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc. Natl. Acad. Sci. USA 1986, 83:4543-4546.
115. Marongiu F., Doratiotto S., Montisci S., Pani P., Laconi E. Liver repopulation and carcinogenesis: two sides of the same coin?. Am J. Pathol. 2008, 172:857-864.
116. Marongiu F., Serra M.P., Sini M., Marongiu M., Contini A., Laconi E. Cell turnover in the repopulated rat liver: distinct lineages for hepatocytes and the biliary epithelium. Cell Tissue Res. 2014, 356:333-430.
117. Mason W., Litwin S. Pathogenesis of hepadnavirus infections. HBV Human Virus Guide 2002, 99-113. International Medical Press, London. S. Locarnini, C.L. Lai (Eds.).
118. Mason W.S., Aldrich C., Summers J., Taylor J.M. Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA. Proc. Natl. Acad. Sci. USA 1982, 79:3997-4001.
119. Mason W.S., Litwin S., Jilbert A.R. Immune selection during chronic hepadnavirus infection. Hepatol. Int. 2008, 2:3-16.
120. Mason W.S., Liu C., Aldrich C.E., Litwin S., Yeh M.M. Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection. J. Virol. 2010, 84:8308-8315.
121. Mason W.S., Low H.C., Xu C., Aldrich C.E., Scougall C.A., Grosse A., Clouston A., Chavez D., Litwin S., Peri S., Jilbert A.R., Lanford R.E. Detection of clonally expanded hepatocytes in chimpanzees with chronic hepatitis B virus infection. J. Virol. 2009, 83:8396-8408.
122. Mason W.S., Seal G., Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 1980, 36:829-836.
123. Mason W.S., Xu C., Low H.C., Saputelli J., Aldrich C.E., Scougall C., Grosse A., Colonno R., Litwin S., Jilbert A.R. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J. Virol. 2009, 83:1778-1789.
124. Meier P., Scougall C.A., Will H., Burrell C.J., Jilbert A.R. A duck hepatitis B virus strain with a knockout mutation in the putative×ORF shows similar infectivity and in vivo growth characteristics to wild-type virus. Virology 2003, 317:291-298.
125. Minor M.M., Slagle B.L. Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system. Viruses 2014, 6:4683-4702.
126. Moolla N., Kew M., Arbuthnot P. Regulatory elements of hepatitis B virus transcription. J. Viral Hepatol. 2002, 9:323-331.
127. Moraleda G., Saputelli J., Aldrich C.E., Averett D., Condreay L., Mason W.S. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 1997, 71:9392-9399.
128. Murakami Y., Saigo K., Takashima H., Minami M., Okanoue T., Brechot C., Paterlini-Brechot P. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 2005, 54:1162-1168.
129. Murray J.M., Wieland S.F., Purcell R.H., Chisari F.V. Dynamics of hepatitis B virus clearance in chimpanzees. Proc. Natl. Acad. Sci. USA 2005, 102:17780-17785.
130. Newbold J.E., Xin H., Tencza M., Sherman G., Dean J., Bowden S., Locarnini S. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J. Virol. 1995, 69:3350-3357.
131. Ni Y., Lempp F.A., Mehrle S., Nkongolo S., Kaufman C., Falth M., Stindt J., Koniger C., Nassal M., Kubitz R., Sultmann H., Urban S. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 2014, 146:1070-1083.
132. Ning X., Nguyen D., Mentzer L., Adams C., Lee H., Ashley R., Hafenstein S., Hu J. Secretion of genome-free hepatitis B virus - single strand blocking model for virion morphogenesis and para-retrovirius. PLoS Pathog. 2011, 7:e1002255.
133. Noguchi C., Ishino H., Tsuge M., Fujimoto Y., Imamura M., Takahashi S., Chayama K. G to A hypermutation of hepatitis B virus. Hepatology 2005, 41:626-633.
134. Nowak M.A., Bonhoeffer S., Hill A.M., Boehme R., Thomas H.C., McDade H. Viral dynamics in hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 1996, 93:4398-4402.
135. Obert S., Zachmann-Brand B., Deindl E., Tucker W., Bartenschlager R., Schaller H. A splice hepadnavirus RNA that is essential for virus replication. EMBO J. 1996, 15:2565-2574.
136. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa Y., Mayumi M. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J. Virol. 1994, 68:8102-8110.
137. Ostapchuk P., Hearing P., Ganem D. A dramatic shift in the transmembrane topology of a viral envelope glycoprotein accompanies hepatitis B viral morphogenesis. EMBO J. 1994, 13:1048-1057.
138. Parekh S., Zoulim F., Ahn S.H., Tsai A., Li J., Kawai S., Khan N., Trepo C., Wands J., Tong S. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J. Virol. 2003, 77:6601-6612.
139. Perlman D.H., Berg E.A., O'Connor P.B., Costello C.E., Hu J. Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids. Proc. Natl. Acad. Sci. USA 2005, 102:9020-9025.
140. Piper R.C., Katzmann D.J. Biogenesis and function of multivesicular bodies. Annu. Rev. Cell Dev. Biol. 2007, 23:519-547.
141. Pollicino T., Cacciola I., Saffioti F., Raimondo G. Hepatitis B virus PreS/S gene variants: pathobiology and clinical implications. J. Hepatol. 2014, 61:408-417.
142. Ponzetto A., Cote P.J., Ford E.C., Purcell R.H., Gerin J.L. Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus. J. Virol. 1984, 52:70-76.
143. Prince A.M., Szmuness W., Michon J., Demaille J., Diebolt G., Linhard J., Quenum C., Sankale M. A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int. J. Cancer 1975, 16:376-383.
144. Purcell R.H., Gerin J.L. Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am. J. Med. Sci. 1975, 270:395-399.
145. Rabe B., Delaleau M., Bischof A., Foss M., Sominskaya I., Pumpens P., Cazenave C., Castroviejo M., Kann M. Nuclear entry of hepatitis B virus capsids involves disintegration to protein dimers followed by nuclear reassociation to capsids. PLoS Pathog. 2009, 5:e1000563.
146. Rabe B., Vlachou A., Pante N., Helenius A., Kann M. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc. Natl. Acad. Sci. USA 2003, 100:9849-9854.
147. Reaiche G.Y., Le Mire M.F., Mason W.S., Jilbert A.R. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology 2010, 406:286-292.
148. Reaiche-Miller G.Y., Thorpe M., Low H.C., Qiao Q., Scougall C.A., Mason W.S., Litwin S., Jilbert A.R. Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver. Virology 2013, 446:357-364.
149. Rehermann B., Ferrari C., Pasquinelli C., Chisari F.V. The hepatitis B virus persists for decades after patients recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat. Med. 1996, 2:1104-1108.
150. Renard C.A., Fourel G., Bralet M.P., Degott C., De La Coste A., Perret C., Tiollais P., Buendia M.A. Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles. Oncogene 2000, 19:2678-2686.
151. Riehle K.J., Dan Y.Y., Campbell J.S., Fausto N. New concepts in liver regeneration. J. Gastroenterol. Hepatol. 2011, 26(Suppl. 1):S203-S212.
152. Robinson W.S., Clayton D.A., Greenman R.L. DNA of a human hepatitis B virus candidate. J. Virol. 1974, 14:384-391.
153. Robinson W.S., Greenman R.L. DNA polymerase in the core of the human hepatitis B virus candidate. J. Virol. 1974, 13:1231-1236.
154. Rodrigues L., Freitas N., Kallakury B.V., Menne S., Gudima S.O. Super-infection with woodchuck hepatitis virus (WHV) strain WHVNY of the livers chronically infected with the strain WHV7. J. Virol. 2014, 89:384-405.
155. Rosler C., Kock J., Kann M., Malim M.H., Blum H.E., Baumert T.F., von Weizsacker F. APOBEC-mediated interference with hepadnavirus production. Hepatology 2005, 42:301-309.
156. Rudnick D.A., Perlmutter D.H. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in generic liver disease. Hepatology 2005, 42:514-521.
157. Sato S., Suzuki K., Akahane Y., Akamatsu K., Akiyama K., Yunomura K., Tsuda F., Tanaka T., Okamoto H., Miyakawa Y., Mayumi M. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann. Int. Med. 1995, 122:241-248.
158. Schaub J.R., Malato Y., Gormond C., Willenbring H. Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Rep. 2014, 8:933-939.
159. Schultz U., Chisari F.V. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J. Virol. 1999, 73:3162-3168.
160. Schultz U., Summers J., Staeheli P., Chisari F.V. Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes. J. Virol. 1999, 73:5459-5465.
161. Seeger C., Ganem D., Varmus H.E. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 1986, 232:477-484.
162. Seeger C., Sohn J.A. Targeting hepatitis B virus with CRISPR/Cas9. Mol. Ther. Nucleic Acids 2014, 3:e216.
163. Seeger C., Zoulim F., Mason W.S. Hepadnaviruses. Fields Virology 2013, 2185-2221. Lippincott, Williams and Wilkins, Philadelphia. 6th ed. D.M. Knipe, P. Howley (Eds.).
164. Sells M.A., Chen M., Acs G. Production of hepatitis B virus particles in hepG2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 1987, 84:1005-1009.
165. Senior J.R., Sutnick A.L., Goeser E., London W.T., Dahlke M.B., blumberg B.S. Reduction of post-transfusion hepatitis by exclusion of Australia antigen from donor blook in an urban public hospital. Am. J. Med. Sci. 1974, 267:171-177.
166. Seo J.H., Kim K.W., Murakami S., Park B.C. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma. J. Korean Med. Sci. 1997, 12:523-531.
167. Shih C.H., Li L.S., Roychoudhury S., Ho M.H. In vitro propagation of human hepatitis B virus in a rat hepatoma cell line. Proc. Natl. Acad. Sci. USA 1989, 86:6323-6327.
168. Shimizu Y., Kiamoto O. The incidence of viral hepatitis after blood transfusions. Gastroenterology 1963, 44:740-744.
169. Soussan P., Tuveri R., Nalpas B., Garreau F., Zavala F., Masson A., Pol S., Brechot C., Kremsdorf D. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J. Hepatol. 2003, 38:343-348.
170. Su I.J., Wang H.C., Wu H.C., Huang W.Y. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 2008, 23:1169-1174.
171. Su Q., Schroder C.H., Hofmann W.J., Otto G., Pichlmayr R., Bannasch P. Expression of hepatitis B virus×protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 1998, 27:1109-1120.
172. Summers J., Jilbert A.R., Yang W., Aldrich C.E., Saputelli J., Litwin S., Toll E., Mason W.S. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc. Natl. Acad. Sci. USA 2003, 100:11652-11659.
173. Summers J., Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982, 29:403-415.
174. Summers J., O'Connell A., Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Natl. Acad. Sci. USA 1975, 72:4597-4601.
175. Summers J., Smith P.M., Horwich A.L. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 1990, 64:2819-2824.
176. Summers J., Smolec J.M., Snyder R. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 1978, 75:4533-4537.
177. Sundquist W.I., Krausslich H.G. HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2012, 2:a006924.
178. Sung W.K., Zheng H., Li S., Chen R., Liu X., Li Y., Lee N.P., Lee W.H., Ariyaratne P.N., Tennakoon C., Mulawadi F.H., Wong K.F., Liu A.M., Poon R.T., Fan S.T., Chan K.L., Gong Z., Hu Y., Lin Z., Wang G., Zhang Q., Barber T.D., Chou W.C., Aggarwal A., Hao K., Zhou W., Zhang C., Hardwick J., Buser C., Xu J., Kan Z., Dai H., Mao M., Reinhard C., Wang J., Luk J.M. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 2012, 44:765-769.
179. Sureau C., Romet L.J., Mullins J.I., Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 1986, 47:37-47.
180. Suspene R., Guetard D., Henry M., Sommer P., Wain-Hobson S., Vartanian J.P. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2005, 102:8321-8326.
181. Tagawa M., Omata M., Okuda K. Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection. Virology 1986, 152:477-482.
182. Tana M.M., Hoofnagle J.H. Scar undone: long-term therapy of hepatitis B. Lancet 2013, 381:433-434.
183. Tarlow B.D., Pelz C., Naugler W.E., Wakefield L., Wilson E.M., Finegold M.J., Grompe M. Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 2014, 15:605-618.
184. Taylor J.M. Structure and replication of hepatitis delta virus RNA. Curr. Top. Microbiol. Immunol. 2006, 307:1-23.
185. Tennant B.C., Gerin J.L. The woodchuck model of hepatitis B virus infection. ILAR J. 2001, 42:89-102.
186. Terradillos O., Billet O., Renard C.A., Levy R., Molina T., Briand P., Buendia M.A. The hepatitis B virus×gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997, 14:395-404.
187. Tsurimoto T., Fujiyama A., Matsubara K. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc. Natl. Acad. Sci. USA 1987, 84:444-448.
188. Tuttleman J.S., Pourcel C., Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986, 47:451-460.
189. Tuttleman J.S., Pugh J.C., Summers J.W. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J. Virol. 1986, 58:17-25.
190. Walter E., Keist R., Niederost B., Pult I., Blum H.E. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996, 24:1-5.
191. Wang G.H., Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 1992, 71:663-670.
192. Wang H., Ryu W.S. Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog. 2010, 6:e1000986.
193. Wang H.Y., Chien M.H., Huang H.P., Chang H.C., Wu C.C., Chen P.J., Chang M.H., Chen D.S. Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases. J. Virol. 2010, 84:3454-3463.
194. Wang J., Chenivesse X., Henglein B., Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 1990, 343:555-557.
195. Wang M.J., Chen F., Li J.X., Liu C.C., Zhang H.B., Xia Y., Yu B., You P., Xiang D., Lu L., Yao H., Borjigin U., Yang G.S., Wangensteen K.J., He Z.Y., Wang X., Hu Y.P. Reversal of hepatocyte senescence after continuous in vivo cell proliferation. Hepatology 2014, 60:349-361.
196. Warren K.S., Heeney J.L., Swan R.A., Heriyanto, Verschoor E.J. A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus). J. Virol. 1999, 73:7860-7865.
197. Watanabe T., Sorensen E.M., Naito A., Schott M., Kim S., Ahlquist P. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc. Natl. Acad. Sci. USA 2007, 104:10205-10210.
198. Watts N.R., Conway J.F., Cheng N., Stahl S.J., Belnap D.M., Steven A.C., Wingfield P.T. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J. 2002, 21:876-884.
199. Weber M., Bronsema V., Bartos H., Bosserhoff A., Bartenschlager R., Schaller H. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J. Virol. 1994, 68:2994-2999.
200. Wen W.H., Chang M.H., Zhao L.L., Ni Y.H., Hsu H.Y., Wu J.F., Chen P.J., Chen D.S., Chen H.L. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J. Hepatol. 2013, 59:24-30.
201. Wieland S., Thimme R., Purcell R.H., Chisari F.V. Genomic analysis of the host response to hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 2004, 101:6669-6674.
202. Wieland S.F., Eustaquio A., Whitten-Bauer C., Boyd B., Chisari F.V. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc. Natl. Acad. Sci USA 2005, 102:9913-9917.
203. Wieland S.F., Spangenberg H.C., Thimme R., PUrcell R.H., Chisari F.V. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc. Natl. Acad. Sci. USA 2004, 101:2129-2134.
204. Will H., Reiser W., Weimer T., Pfaff E., Buscher M., Sprengel R., Cattaneo R., Schaller H. Replication strategy of human hepatitis B virus. J. Virol. 1987, 61:904-911.
205. Wong G.L., Wong V.W., Chan H.L. Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B. J. Viral. Hepatol. 2014, 21:825-834.
206. Yaginuma K., Shirakata Y., Kobayashi M., Koike K. Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA. Proc. Natl. Acad. Sci. USA 1987, 84:2678-2682.
207. Yan H., Peng B., He W., Zhong G., Qi Y., Ren B., Gao Z., Jing Z., Song M., Xu G., Sui J., Li W. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide. J. Virol. 2013, 87:7977-7991.
208. Yan H., Zhong G., Xu G., He W., Jing Z., Gao Z., Huang Y., Qi Y., Peng B., Wang H., Fu L., Song M., Chen P., Gao W., Ren B., Sun Y., Cai T., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 2012, 1:e00049.
209. Yang D., Alt E., Rogler C.E. Coordinate expression of N-myc 2 and insulin-like growth factor II in pre-cancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res. 1993, 53:2020-2027.
210. Yang W., Mason W.S., Summers J. Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J. Virol. 1996, 70:4567-4575.
211. Yang W., Summers J. Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination. J. Virol. 1995, 69:4029-4036.
212. Yang W., Summers J. Integration of hepadnavirus DNA in infected liver: evidence from a linear precursor. J. Virol. 1999, 73:9710-9717.
213. Yanger K., Knigin D., Zong Y., Maggs L., Gu G., Akiyama H., Pikarsky E., Stanger B.Z. Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 2014, 15:340-349.
214. Yao E., Gong Y., Chen N., Tavis JE. The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure. J Virol. 2000, 74(18):8648-8657.
215. Yim H.J., Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 2006, 43:S173-S181.
216. Yu X., Mertz J.E. Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated. J. Virol. 1996, 70:8719-8726.
217. Zhang Y.Y., Summers J. Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections. J. Virol. 1999, 73:3616-3622.
218. Zhang Z., Torii N., Hu Z., Jacob J., Liang T.J. X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J. Clin. Invest. 2001, 108:1523-1531.
219. Zhong G., Yan H., Wang H., He W., Jing Z., Qi Y., Fu L., Gao Z., Huang Y., Xu G., Feng X., Sui J., Li W. Sodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes. J. Virol. 2013, 87:7176-7184.
220. Zhu Y., Yamamoto T., Cullen J., Saputelli J., Aldrich C.E., Miller D.S., Litwin S., Furman P.A., Jilbert A.R., Mason W.S. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J. Virol. 2001, 75:311-322.
221. Zoulim F., Mason W.S. Reasons to consider earlier treatment of chronic HBV infections. Gut 2012, 61:333-336.
222. Zoulim F., Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J. Virol. 1994, 68:6-13.
223. Zuckerman A.J., Thornton A., Howard C.R., Tsiquaye K.N., Jones D.M., Brambell M.R. Hepatitis B outbreak among chimpanzees at the London Zoo. Lancet 1978, 2:652-654.